Persistent diarrhea is an important cause of morbidity in returned travelers. We performed a case-control study to determine the role of diarrheagenic Escherichia coli in acute and persistent diarrhea in returned travelers who presented at an out-patient department for tropical diseases in Amsterdam (The Netherlands) and Antwerp (Belgium).
Introduction
Millions of people travel from industrialized to developing countries each year.
Traveler's diarrhea is the most common disorder encountered by these travelers during their journey and thereafter. Although traveler's diarrhea generally lasts less than a week (1), approximately 3% of international travelers to high-risk areas develop persistent diarrhea. By definition the duration of persistent diarrhea is at least 14 days (2) but it may last several months to a year. In approximately 50% of travelers with persistent diarrhea, diarrhea lasts more than 30 days (3). Beside travelers, persistent diarrhea is also a major cause of morbidity in expatriates and other long-term foreign residents in developing countries (4, 5) The etiology of persistent diarrhea in travelers remains unknown in at least 50% of cases (3, 6) . While the etiology of acute traveler's diarrhea has been studied extensively, there are only a few reports in which the etiology of persistent diarrhea in travelers and foreign residents is studied. Although enterotoxigenic E. coli (ETEC) is considered to be the most important cause of acute traveler's diarrhea (1), it has rarely been implicated as a cause of persistent diarrhea in travelers (4) . In view of the possible association of enteroaggregative E. coli (EAggEC) with persistent diarrhea in children in developing countries (7) (8) (9) , it has been suggested that EAggEC may also be a cause of persistent diarrhea in travelers. In a recent case-control study in Spain , EAggEC was isolated in 16 (10%) of 165 returned travelers with diarrhea, of whom 5 (30%) had persistent diarrhea, and in only 4 (2%) of 165 controls (10).
The clinical presentation of diarrhea due to EAggEC was similar to diarrhea caused by ETEC.
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Enteropathogenic E. coli (EPEC) and diffuse adherent E. coli (DAEC) have not been associated with traveler's diarrhea. However, in a small number of studies such E. coli were associated with persistent diarrhea(l 1-14) in children.
We performed a case-control study to determine the role of ETEC and EAggEC in acute and persistent diarrhea in returned travelers. In addition, the presence of DAEC and EPEC was determined.
Materials and Methods

Definitions
Diarrhea was defined as at least three loose stools in 24 hours, or any number of watery stools, or 1 or 2 loose stools in 24 hours accompanied by at least one of the following symptoms: nausea, vomiting, abdominal cramps, fever > 38 C.
Acute diarrhea was defined as diarrhea which lasted 14 days or less at the time of presentation.
Persistent diarrhea was defined as diarrhea which lasted for more than 14 days at presentation.
When diarrhea was present intermittently, it was considered persistent when diarrhea occurred during at least 6 days in a 2 weeks period.
Patients and controls
Patients were included who presented with diarrhea from December 1995 to August 1996, at the out-patient department for Tropical Diseases at the Academic Medical Centre, Amsterdam, and the Leopold Institute of Tropical Medicine, Antwerp. Cases were defined as patients who developed diarrhea during a stay in tropical areas or within the first two weeks after their return.
Included as controls were the first consecutive individuals after each case who, after a stay in tropical areas, presented at the out-patient departments for other reasons than diarrhea and who did not experience diarrhea in the previous 2 months. Both cases and controls were requested to submit a stool sample at their first visit at the out-patient departments.
From both cases and controls, data were collected, including age, sex, geographic area visited and duration of their journey, date of return, and use of antimicrobial therapy during or after their trip. From patients with diarrhea, a detailed clinical history was obtained.
Investigation of stool samples
Stool samples from patients and controls were collected on the day of presentation at the out-patient department, immediately transported to the laboratory, stored at 4 C and processed within 24 hours.
Detection of diarrheagenic Escherichia coli
Stool samples were inoculated onto CLED agar plates and, after incubation for 18 '.rsurs at 37°C, a "sweep" of the complete bacterial growth on the agar was collected using a sterile cotton swab, and stored in glycerol-pepton at -70°C, as described previously (15) .
Detection of diarrheagenic E. coli was performed in the Medical Microbiology laboratory in Amsterdam. The frozen sweeps collected in Antwerp were transported on dry ice to Amsterdam within one day. To test the sweep, after thawing, the material was inoculated on a CLED agar plate and a second sweep was made. This sweep was diluted in PBS and subjected to PCR for detection of ETEC as described previously (15) . In addition, 3 ul of the diluted sweep was spotted on nylon filters (Hybond-N, Amersham Nederland BV) overlying nutrient agar plates and grown for 6 hours at 37°C. Growth on the filters was lysed and denatured as described previously (15) . Membranes, containing positive and negative controls, were hybridized with digoxigenine (Boehringer Mannheim BV, The Netherlands) labeled polynucleotide DNA-probes for detection of EAggEC (16) , DAEC (daaC){ 17) and attachingeffacingE. coli (eae) (18) .
All stored sweeps which yielded weak to strong signals after hybridization were again inoculated on CLED agar plates and 3 to 5 E. coli-like colonies were isolated and identified biochemically as E. coli. These colonies were tested in a 6-hours HEp-2 adherence assay for phenotypical confirmation of their adherence pattern. Only colonies which yielded an aggregative or diffuse adherence pattern in the Hep-2 test, in addition to positive hybridization with the EAggEC probe or the daaC probe, were considered EAggEC or DAEC respectively.
Isolates which showed an adherence pattern compatible with both EAggEC and DAEC were categorized separately and designated DAAA (Diffuse adherent /Aggregative adherent).
Strains were considered EPEC if they were positive after hybridization with the eae-probe and showed localized adherence in the HEp-2 test.
Detection of other enteropathogenic bacteria
All stool samples were inoculated onto Salmonella-Shigella (SS) agar, Cysteine Lactose Electrolyte Deficient (CLED) agar, Hektoen Enteric Agar (HEA), MacConkey agar containing potassium-tellurite, and thiosulfate-citrate-bile salts-sucrose agar, and incubated for 24-48 hours at 37°C. For enrichment, GramNegative-broth (Hajna) was inoculated and after incubation for 24 hours at 42°C, subcultured onto SS-agar and HEA. For selective enrichment of Salmonella species, feces was inoculated onto a semisolid selective-motility enrichment medium (19) , incubated at 37°C and subcultured onto SS-agar. Yersinia species were isolated by inoculation of cefsulodin-irgasan-novobiocin (CTN) agar which was incubated for 48 hours at room temperature. In addition, glucose broth was inoculated and incubated for 1 week at
4°C and subcultured onto CTN agar. For detection of'Campylobacter species, Butzler
Campylobacter selective medium was inoculated and incubated for 48 hours at 42 C under microaerophilic conditions. For isolation of Plesiomonas shigelloses, mannitol-MacConkey agar plates were inoculated and incubated for 18-36 hour at 37°C and at 42°C. All isolates were further characterized using standard microbiological identification methods and commercially available antisera. For detection of Aeromonas species, blood agar plates containing 10 |ig/ml ampicilline were inoculated and incubated for 24-48 hours at 37 C and biochemically characterized as described by Kuijper (20) . The methods used for bacterial culture in Amsterdam and Antwerp were identical.
Parasitological examination
Parasitological investigation of stool samples was performed by direct examination of stool in eosine solution. In addition, samples were concentrated as described by Ridley and examined after staining with potassium-iodine. Stool samples were examined for the presence of ova, cysts and cyclospora. Identical protocols for identification of parasites were used in Amsterdam and Antwerp.
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Data collection and analysis
Clinical data from each patient and control were collected using a questionnaire in Epiinfo format (Amsterdam) or by direct registration in dBase (Antwerp). Data were merged into Epi-info, version 6.0 (CDC, Atlanta). Statistical analysis was performed using Stata"", version 4 (Stata Corporation, Texas). Giardia lamblia and Blastocystis hominis, as the role of these parasites in the etiology of diarrhea in travelers is debatable (1). In addition, the sensitivity of microscopic examination of a single stool specimen for these parasites is relatively low (21) . Cases infected with cyclospora, however, were excluded from analysis.
Crude and adjusted odds ratios were calculated separately for associations of casecontrol status with presence of ETEC, EAggEC and DAEC, EPEC and DAAA, and for each of these associations after stratification for potential confounding variables. These included sex, age, travel destination, duration of stay, interval between return to the Netherlands or Belgium and presentation at the out-patient department, season of return, recent use of antibiotics, presence of G. lamblia or B. hominis, presence of ETEC (for EAggEC associated diarrhea), and institute of study inclusion (Amsterdam or Antwerp). The stratification for travel destination was based on destination-specific diarrhea risks categories for Dutch travelers (22) .
If crude and adjusted odds ratios differed by more than 15% in the simple stratified analysis, the confounding effect was further assessed in a multivariate model using logistic regression.
For each association under study, a final model was constructed including all variables displaying a meaningful confounding effect; the contribution of presence of the pathogen to the model was expressed as an odds ratio with a 95% confidence interval and assessed by the likelihood ratio test for exclusion from that model (23 traveler's diarrhea, diarrhea in returned travelers often lasts more than 2 weeks and in more than 50% no etiology is found (3, 6, 24) . The aim of this study was to evaluate the potential associations between diarrheagenic E. coli and diarrhea of short and prolonged duration in this patient group. In particular, we were interested in the detection rates of ETEC, as the major cause of traveler's diarrhea, and EAggEC, which has been associated with persistent diarrhea in several studies in endemic areas (1,7-9).
In 31% of patients, diarrhea lasted 14 days or less and in these patients a significant association of ETEC with diarrhea was found. This observation is compatible with the well established association of ETEC with classical traveler's diarrhea (1) and with findings from other studies in returned travelers (10,24,25). While ETEC was the pathogen most commonly detected in our patients, it should be taken into account that we used a highly sensitive method for detection of ETEC in stool samples (15) . This method probably has a higher sensitivity than routine stool culture for detection of other common enteropathogens, such as Campylobacter or Shigella.
In patients with acute diarrhea, the frequency of EAggEC was similar to the frequency of ETEC. The role of EAggEC as a cause of diarrhea in travelers is not well established.
Entero-adherent E. coli, a term which includes both EAggEC and DAEC, have been associated with traveler's diarrhea in adults traveling to Mexico (26) . However, at the time of that study, no distinction was made between localized, aggregative and diffuse adhesion of adherent strains, and the contribution of EAggEC in this group is unknown. Increased colonization with EAggEC was observed in adult travelers to Mexico, when comparing stool samples before and after the journey, but no association with diarrhea was found (27) . Finally, in a recent study among 165 returned Spanish travelers with diarrhea and their healthy travel companions, EAggEC was associated with diarrhea, which clinically resembled diarrhea caused by ETEC (10). However, in this study, patients with concurrent other bacterial infections were not excluded from the final statistical analysis. Therefore other pathogens, isolated in 30% of patients with EAggEC, may have accounted for the diarrhea attributed to EAggEC.
Furthermore, EAggEC was detected using PCR on isolated colonies, without phenotypic confirmation of the aggregative adherence pattern. The frequency of true EAggEC in this patient group may therefore have been slightly lower than reported.
In the present study, true EAggEC was found significantly more often in patients with diarrhea of short duration than in controls The detection rate of EAggEC was similar to that found in the Spanish travelers (10). However, we found polymicrobial infection, particularly co-infection with ETEC, in 6 of 17 (35%) patients with EAggEC In addition, the use of antibiotics by cases with EAggEC and controls was different (table 4) . This may account for the lack of association of EAggEC with acute diarrhea in our multi-variate model (table 6) .
However, it cannot be excluded that EAggEC, and not ETEC, caused diarrhea in these patients. Additional studies, including larger sized case-and control groups, are therefore required to further evaluate the possible association of EAggEC with diarrhea of short duration in returned travelers, especially since co-infection of ETEC and EAggEC may be a common phenomenon, considering the comparable distribution of the two categories of E. coli among the geographic regions.
The majority of the patients (68%) presented with persistent diarrhea, lasting more than 3 months in 25%. Neither ETEC nor EAggEC were associated with persistent diarrhea. In a study in Nepal, ETEC was found in 19% of 37 travelers and foreign residents, who had diarrhea for more than 14 days. However, this study was performed in an endemic area and no control group of individuals without diarrhea was included (4). EAggEC has been associated with persistent diarrhea in children in endemic areas in a number of studies (7-9), but to our knowledge no data are available demonstrating an association of EAggEC in travelers with persistent diarrhea.
DAEC was detected in a relatively high frequency among cases and controls. The potential role of DAEC as an enteric pathogen is not well established (28) . DAEC was detected in stool samples in 20% of both adult patients with ulcerative colitis and healthy controls in the Netherlands, who did not travel during the year before the investigation (29) .
The latter findings suggest that DAEC are commonly present in stool samples from adults in the Netherlands and explain the lack of an association with diarrhea in travelers from tropical areas. The existence of a diarrheagenic subpopulation of DAEC can not be excluded but detection of such strains will require identification of associated virulence factors or other markers, in addition to the methods presently used.
Since EPEC, similar to ETEC, is a common cause of childhood diarrhea in developing countries, several studies have investigated the role of EPEC in acute traveler's diarrhea (10,24,27,30), using either serotyping or DNA probes for detection of EPEC. In none of these studies, EPEC was significantly associated with diarrhea, which is confirmed by our study. In addition, our results indicate that EPEC is also not associated with persistent diarrhea in travelers. The category of E. coli strains which hybridize with both the daaC probe and the EAggEC fragment probe and which show a mixed adherence pattern to HEp-2 cells, has been recognized before (31) . We chose to evaluate the individuals with such strains separately from those infected with DAEC or EAggEC since it is not clear to which category of diarrheagenic E. coli the strains belong and their pathogenic potential has not been evaluated.
The presence of other diarrheagenic E. coli, in particular verotoxigenic E. coli (VTEC) and entero-invasive E. coli, was not investigated in the current study. However, we did not detect any of these pathogens in a pilot study among 50 returned travelers (32) , and therefore did not expect to find any association with diarrhea in the present study.
We found a potential cause of diarrhea in less than 50% of patients. ETEC and EAggEC were the (putative) enteropathogens isolated most frequently. Twenty-eight percent of patients used antibiotics during the course of their disease, which may have influenced the detection rates of pathogens. This detection rate is, however, comparable with rates reported by others (25) . Studies among children with persistent diarrhea in endemic countries seldomly show a specific pathogen which is exclusively associated with persistent diarrhea. In these children, re-infection with common pathogens is more likely to occur and persistent diarrhea is likely to develop due to sequential infection after continous or repeated exposure (11, 33, 34) .
The situation in our patient group is totally different. Although we did not study consecutive stool samples from individual patients, sequential infection is less likely to have occurred, considering the relatively short stay abroad , and the often prolonged period between return from the journey and presentation with diarrhea at the clinic (table 1) . Instead, symptoms in travelers with persistent diarrhea may be associated with diarrhea-predominant Irritable Bowel Syndrome (IBS), which has been shown to occur after acute gastroenteritis (35) . Although it is unclear what causes persistent diarrhea in the majority of our patients, several reports indicate that persistent diarrhea, which has developed after a bout of acute diarrhea and for which no cause is found, is self-limited, although symptoms may persist for periods as long as a year (3, 6, 36) . Patients with persistent diarrhea after travel, without identifiable cause, should therefore not receive recurrent antimicrobial therapy.
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